Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21320923 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
Condition: HIV Infections
Interventions: Drug: Abacavir/Lamivudine;   Drug: Atazanavir;   Drug: Efavirenz;   Drug: Emtricitabine/Tenofovir disoproxil fumarate;   Drug: Ritonavir;   Drug: Abacavir/Lamivudine placebo;   Drug: Emtricitabine/Tenofovir disoproxil fumarate placebo

Indicates status has not been verified in more than two years